Skip to main content

Teladoc draws another target revision on Wall Street; this time on chronic care outlook

By Seeking Alpha  
   February 08, 2022

A day after Bank of America lowered its price target on Teladoc Health (TDOC -5.0%) by as much as a third, Piper Sandler has followed suit. Citing a bleak outlook for the company's Chronic Care Enrollments in Q1 2022, the analyst Sean Wieland lowered the per share target on the telehealth provider to $108 from $118 to indicate a premium of ~45% to the last close.

Full story


Get the latest on healthcare leadership in your inbox.